Life ScienceCompany
Shire has acquired 16 companies of its own, including 1 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 3 assets.
Shire’s largest acquisition to date was in 2016, when it acquired Baxalta for $32.0B. Shire has acquired in 7 different US states, and 4 countries. The Company’s most targeted sectors include life science (94%) and healthcare services (7%).
Join Mergr and gain access to Shire’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity19
- M&A Buy Activity16
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 7
- M&A Advisors 11